Vivien Burt, M.D., a specialist in bipolar disorder, discusses the complexities of managing this condition during pregnancy. She emphasizes the critical balance between maternal mental health and fetal safety. The conversation covers the risks and benefits of medications like lithium and lamotrigine. Individualized treatment plans are highlighted as essential for effective care. The episode also explores recent research and guidelines for navigating these unique challenges, ensuring the well-being of both mother and child.

Dr. Vivien Burt, a specialist in postpartum depression and anxiety, discusses brexanolone, an FDA-approved medication for postpartum depression. She explains its unique properties, including its quick onset of action and ongoing study for severe anxiety and insomnia. The podcast explores a randomized study on brexanolone, its effects on depressive symptoms, anxiety, and insomnia. It also highlights the limitations of the study, administration method, potential side effects, and cost of the medication, while emphasizing its potential as a first-step treatment.

Vivien Burt, Professor Emeritus of Psychiatry at UCLA, discusses the intricate decision-making process surrounding atypical antipsychotics use during pregnancy, particularly for women with bipolar disorder. She highlights recent research showing no significant risk of major birth defects, emphasizing the need to balance maternal mental health with fetal safety. The conversation stresses the importance of effective communication between healthcare providers and patients to navigate treatment benefits and potential risks for newborns.